chrisvoncsefalvay/vaers-outcomes huggingface dataset:
devel measle-like sx-rash, fever, swollen glands, sore throat; rash covered entire body; t104;
This spontaneous report as received from a Medical Assistant refers to 15 year old patient, gender not reported. On 11-NOV-2014, the patient was vaccinated with GARDASIL, Lot # K004204, dose unspecified. It was reported that the administered vaccine was subjected to temperature excursion during storage. No adverse event reported. This is one of the several reports from the same reporter. Additional information has been requested.
Child was seen at office today 2-11-16 and mother reported that child had a fever at 106 the night he got his vaccines  2-1-16. No other problems noted. Mother gave bath and gave TYLENOL and fever was gone. No other problem or reactions. Today was first report of this.
weakness; noodle legs; excruciating headache; vomit; extremely nauseous; freezing cold with chills; passed out; weak tingling feeling; loose bowels; low grade temp of 96; sore arm; total, severe exhaustion; A Spontaneous report was received from a consumer concerning herself a 67-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced passed out/loss of consciousness, severe exhaustion/fatigue, sore arm/ pain in extremity, extremely nauseous, weak tingling feeling/Paresthesia , vomiting, freezing cold with chills, loose bowels/diarrhea, low grade temp of 96/body temperature decreased, excruciating headache, weakness/asthenia, noodle legs/muscular weakness.      The patient's medical history was not included. Concomitant medications were not listed.   On 23 Feb 2021 prior to the onset of events the patients received first dose of their two planned doses of mRNA-1273 (Batch N0:023M7) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection.  On 23 Feb 2021, She felt total, severe exhaustion until Saturday 27 Feb 2021. She woke up with a sore arm on 24 Feb 2021.   On Sunday 28 Feb 2021, she felt extremely nauseous. She had a weak tingling feeling; she started seeing spots and passed out. When she came to, she started to vomit, was freezing cold with chills, then had loose bowels. She had a low-grade temp of 96. She had excruciating headaches. She had weakness; she has noodle legs  The event passed out/loss of consciousness was medically significant and serious.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events, severe exhaustion was resolved on 27 Feb 2021, and outcome of event passed out resolved on unknown date. The outcome of the events sore arm, extremely nauseous, weak tingling feeling, vomiting, freezing cold with chills, loose bowels, low grade temp of 96, excruciating headache, weakness, noodle legs were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments:  MOD-2021-035997:Same Reporter, Different Patient
Pt experienced fainting speel right after vaccination. BP 107/73; HR 68; RR 16; T 98.4 & pt stable and d/c'd home with father
she had the virus last year; she had the virus last year; This is a spontaneous report from a non-contactable consumer, the patient, via the Pfizer-sponsored program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (at an unspecified age) as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in 2020 (reported as last year), the patient "had the virus". It was not confirmed if the patient received the 1st dose of the vaccination prior to or after having the virus. The patient queried if she should continue to receive the 2nd dose. The clinical outcome of "had the virus" was unknown.   No follow-up attempts are possible; Information about batch/lot number cannot be obtained.
45 minutes after the 1st dose, I had anaphylactic reaction. My chest and face was getting hot. My throat started having a hard time swallowing. I went to the ER and I was given IV steroids, Benadryl and Pepcid AC. They did a complete blood work and everything came normal. I started to feel better immediately and after a few hours, I was discharged. I did follow up with my PCP the next day and was instructed to take 2 Benadryl and monitor for at least 1 hours if I proceed with getting the 2nd dose of the vaccine. I did get the second and had no issues.
Diagnosed with Covid-19 via Rapid Test on 04/30/2021.  Received Pfizer vaccines in Feb 2021. Took Covid Rapid Test (NEGATIVE) on 04/18/2021 prior to leaving for vacation home.  Arrived in 04/22/2021 and only went out in public twice, both times masked and social distancing.  On 04/26/2021 I started having flu like symptoms, cough, fever (99-100 degrees F), headache, body aches, shortness of breath.  04/27/2021 I lost my sense of smell and taste. 04/30/2021 since I was still feeling unwell, I went to Urgent Care in for evaluation. Rapid Covid test POSITIVE for CV-19. Prescribed rest, fluids, Tylenol for fever and monitor breathing. Returned home 05/07/2021.  As of today, 05/13/2021 I continue to have cough, lack of taste and mild shortness of breath and feeling generally lousy.
Vaccine injection was at 11:30am then around 7:00 pm developed severe generalized back pain. She has taken Tylenol and Ibuprofen without relief.  At the time of clinic visit, injection site pain was very minimal but was continuing to have severe back pain. Pt. was very tearful. She was given a Toradol injection and placed on muscle relaxers. (cyclobenzaprine 5mg 1-2 bid prn). She was instructed to f/u with provide over the next 48 hours.
Pt received a dose of moderna vaccine although it is not recommended for patients under 18 years of age. Pt's parent was notified after this error was discovered. Pt is not experiencing any adverse reactions at this time. Manufacturer will be contacted for guidance on next steps for this patient regarding further vaccination.
Dizziness, Myalgia,  weakness Narrative: Per nursing report: "called to report took Moderna vaccine on Monday 7-26-21. She states her off day was Tuesday. States worked Wednesday  and Thursday but didn't start having symptoms until Wednesday [7/28]. C/o weakness, soreness and dizziness Wednesday [7/28] and Thursday [7/29]. States not at work today [7/30] due to not feeling good."
This spontaneous report as received from a registered pharmacist refers to unknown number of patients. On an unspecified date the patients were vaccinated with a dose of GARDASIL (lot # not reported) that were exposed to negative 1 degrees C for 3 hours. No adverse effect reported. It was unknown if the patient sought medical attention or not. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.
Acute pain, arm hot and swollen X 12 hours after immunization. Swelling increased for 24 hours. Stabbing pain in waves for 4-5 days. Arm remained swollen (4 in. in diameter, raised 2-3 cms) & red & hot for 10-14 days.
Was seen in the Emergency Department and they found a blood clot in one of my lungs. Was started on Xarelto starter pack and to follow up with PCP. 10 days after starting Xarelto I returned to the ER for chest pain and shortness of breath. Along with vaginal bleeding. followed up with PCP whom referred me to Gynacologist ASAP because I have been bleeding vaginally heavy and with clots since stating the Xarelto.
COVID: Good O2 saturation, no hypoxemia, received 3 days of remdesivir early in hospital course, discontinued due to Transaminitis. 10-day isolation since no hypoxemia. Symptoms started 8/26, so I calculate 10-day isolation through 9/4/2022.
Two weeks after the second the dose, he woke up to a swollen eye. No redness, itching or infection involved just swelling. The swelling went away after 4 days and the other eye swelled up.  Even though he wears glasses permanently he has never had issues with his eyes other than vision impairment. Now, having one eye swell up from time to time worries me because like I said he has vision problems and having one eye shut down makes it difficult to do everyday tasks as it is follwed by a headache. Other family members are having the same issue after their third dose but they don't feel comfortable reporting it even though they share the same opinion about an unbearable migraine like headache.
Two days after the shot, I've had severe depression.  Difficult to think and get out of bed.  Suicidal thoughts; Two days after the shot, I've had severe depression.  Difficult to think and get out of bed.  Suicidal thoughts; Two days after the shot, I've had severe depression.  Difficult to think and get out of bed.  Suicidal thoughts; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration, administered in left arm on 03Mar2021 17:45 as single dose for covid-19 immunisation at a Pharmacy/Drug Store. Medical history included anxiety and allergies to Penicillin and sulfar drugs. The patient had no Covid prior vaccination and was not tested for Covid post vaccination. Concomitant medication included buspirone hydrochloride (BUSPAR). The patient had no other vaccine in four weeks. On 05Mar2021 17:30, two days after the shot, the patient had severe depression, difficult to think and get out of bed and suicidal thoughts. The events were not treated. The outcome of the events was recovering.  Information on the batch/lot number has been requested.
Fever of 102 degrees F the day after shots. PENTACEL. PREVNAR 13, ROTATEQ. Also has congestion and runny nose.
allergic reaction; hives; trouble breathing; itchy; This is a spontaneous report from a non-contactable consumer or other non hcp (patient).   A female patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced allergic reaction, hives, trouble breathing and itchy on an unspecified date.  Course of events was as follows: She had an allergic reaction to the Pfizer Covid vaccine. It gave her hives, and trouble breathing. She had hives and they were itchy all over. She went to the hospital. They had to give her Epipen 0.3 mg injection at an unknown dose and frequency via unknown route for allergic reaction. The outcome of events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Started with increased temp 103 degrees on 5-24-10 @ 8pm. Presented in office on 5-26-10 (R) arm red 22 cm x 15 cm on upper arm from shoulder to upper forearm. Red/hard/warm/painful/itchy. Several sm. blisters noted on skin (fluid filled) (L) bicep measured 22 cm in diam/ (R) bicep 27 cm in diam. (L) forearm 191/2 cm in diam/(R) forearm 24 cm in diam.
Patient experiencing red, blotchy rash 2 days past injection. Rash is on trunk and arms at this time.
Started breaking out behind my left knee. Still have breakout that looks like streaks across back left calf.
This medically confirmed spontaneous report (initial receipt: 18-Oct-2012) concerns a female patient, who had allergy to sulfa antibiotics. On an unknown date the patient received a flu vaccine (manufacturer, brand name and batch number were not provided) and had trouble breathing. The event outcome was not reported. On 18-Oct-2012 the pharmacist considered event to be serious as it was life-threatening and resulted in significant disability or incapacity.
FLU LIKE SYMPTOMS WITH FEVER, RED ARMS STARTING THE EVENING OF DAY OF VACCINE ADMINISTRATION.
30 minutes after vaccine administration, patient noted weakness in both legs and inability to walk. patient was examined, in no acute distress. vitals showed mild hypertension. exam showed mild right lower extremity weakness. The patient was sent to the ER for evaluation for stroke.
Chest pain radiating through to back and nausea.  Treated by on-site staff and transported to local ER.
This is serious spontaneous case, initially received on 26-Jan-2018, reported by other non-health professional, concerning a patient of unspecified age and gender. On 30-Sep-2017, the patient was administered with FLUCELVAX QIV (batch number: 195210, expiry date: 31-Mar-2018, dose, route of administration, anatomical location: not reported). On 23-Jan-2018, the patient experienced fever (temperature between 103-104), sore throat, cough, loss of energy or appetite. On 25-Jan-2018, after 3 months 27 days of vaccination, the patient was diagnosed with type A Influenza [considered as vaccination failure (lack of efficacy)]. This case was associated with product quality assurance investigation report (QAIR) and the corresponding reference number was 1027573. The QA investigation was performed, and it was concluded that FLUCELVAX 195210 was manufactured in compliance with the approved internal procedures and in accordance with the quality requirements. No evidence was found that the LOE (lack of efficacy) complaint was the result of the fill finish or bulk manufacturing process and no trends were identified for the batch, or any other FLUCELVAX QIV batches from the 2017-2018 FLUCELVAX commercial season. Therefore, no internal root cause was confirmed. At the time of this report, the outcome of the event influenza was not reported. Non-significant follow up received from Quality Assurance department on 05-Feb-2018: QAIR reference number 1027573 was added. Amended narrative accordingly. Follow-up received from the quality assurance (QA) department on 13-Mar-2018: The QA investigation was performed, and it was concluded that FLUCELVAX 195210 was manufactured in compliance with the approved internal procedures and in accordance with the quality requirements. No evidence was found that the LOE (lack of efficacy) complaint was the result of the fill finish or bulk manufacturing process and no trends were identified for the batch, or any other FLUCELVAX QIV batches from the 2017-2018 FLUCELVAX Commercial season. Therefore, no internal root cause was confirmed. The expiry date (31-Mar-2018) of the suspect vaccine was added in the product tab. Narrative was amended accordingly. Update 04-Jul-2018: Non-significant case correction with IRD 26-Jan-2018: The case comment was corrected. No changes were done in the narrative.
Light headed to point of almost passing out (10 minutes), weakness (1 hour), sweating (30 minutes), fast heartrate(30 minutes), felt really warm (45 minutes), mind fog (2 hours), felt really loopy almost like a high (2 hours)
Unknown information regarding side effects from first Moderna Covid vaccine.  Second Covid vaccine on 2/12/2021 and there were no issues.  Patient died on 31/10/2021.  Postmortem Covid test is negative for SARS-CoV2 RNA.
My period came on much stronger after the vaccine, with the most significant change being in my cramps. I normally get cramps during the first couple days of my cycle, but never bad enough that it affects my life. After my first menstrual cycle after my first dose, my cramps were strong enough to wake me up in the middle of the night.  My second cycle, which follows my second dose, had the same effect. I was woken up this morning with significant cramp pain and had to take medication to be able to get to work.  It isn't a super serious side effect, but I'd definitely be interested in learning more about why that happened. I can't say for certain whether my flow was impacted or not.
Fever; Bad sore throat; Coughing; Sweating at night; Headache; Body sore; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 12Jun2021 at 15:00(at the age of 14-years-old) as a single dose for COVID-19 immunisation. The patient had no other health issues and the patient was allergic to amoxicillin (MANUFACTURER UNKNOWN). The patient did not receive any concomitant medications within two weeks of the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 22May2021 at 11:00 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Patient didn't have covid-19 prior to the vaccination, and patient didn't have covid test post vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Jun2021 at 06:00 the patient experienced fever which lasted about 12 hours, still having very bad sore throat and coughing on day three after the vaccination, sweating at night, headache and body sore. The patient reported that the symptoms were not noticeably improving. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken included treatment with Tylenol Cold and Flu. The clinical outcome of the event fever was recovered on 13Jun2021 at 18:00 and the clinical outcome the events bad sore throat, coughing, sweating at night, headache and body sore was not recovered at the time of this report.   The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
It's been a month and my arm still aches in the muscle at the injection area. I've had weird leg and chest pains as well, I plan to see doctor
Wed 4/19/2023 unclear guidance given to us on change w/ covid vaccine. monovalent no longer allowed to be given. Bivalent should no be given. Gave child Bivalent vaccine for 6mo-5yrs. When in fact supped to give child vaccine for 6+. child 7 month old. lower dose was given. very poor guidance given to pediatric offices for new covid vaccine recommendations. As of 4/19/2023 when monovalent vaccine was no longer allowed to be given the only Bivalent listed in system for 6months. 5yr was a pink cap/yellow label. As of now we still have to received any guidance or reasoning as to why the 6yrs+ vaccine is to be given to those 6months-5yrs. Information was corrected in system to reflect "colors" or vials but still no guidance on he vaccine itself. That is why mistake was made.
This could be purely a coincidence, but 18 days ( on 03/07/2012) after my first injection on 02/17/2021 I started having some pain, burning and tingling under and around my right arm. Note the first injection was in the left arm. I saw my doctor 2 days later for a normally scheduled appointment. He said he thought I had aggravated a nerve  and that i should get a Shingles vaccine as soon as I could after I finished the Covid Vaccine. I received the second dose on 03/11/2012 and then the day on 03/12/2021 i began breaking out with Shingles.  Again this is probably purely a coincidence but I thought I should report it just in case.
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details: Patient also reported a history of low blood sugar and anemia . She carries glucose tablets in her bag .She took one of the Glucose tablets when she felt dizzy about 10 mins after recieving the shot. She requested not to call  EMS but we did and they arrived and took care of her. She was able to walk out of the pahrmacy unassisted
Death; This spontaneous case was reported by a health care professional and describes the occurrence of DEATH (Death) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   No treatment information was provided.  Company comment This is a spontaneous case concerning a patient of an unknown age and gender with no medical history reported, who experienced the Fatal unexpected, event of death, which occurred on an unknown date, thus latency between vaccination and the event cannot be assessed. The patient received the second dose of mRNA-1273. Death occurred on an unknown date. The cause of death was not reported. It is unknown if an autopsy was performed. No further information regarding the course of events, lab tests, imaging studies and treatment was provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 22-Feb-2021: Upon internal Review on 01-Jun-2022, significant correction was made to update report type, suspect product and narrative.; Sender's Comments: This is a spontaneous case concerning a patient of an unknown age and gender with no medical history reported, who experienced the Fatal unexpected, event of death, which occurred on an unknown date, thus latency between vaccination and the event cannot be assessed. The patient received the second dose of mRNA-1273. Death occurred on an unknown date. The cause of death was not reported. It is unknown if an autopsy was performed. No further information regarding the course of events, lab tests, imaging studies and treatment was provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Reported Cause(s) of Death: unknown cause of death
Local reaction 2-4 x a day with itching, nausea, malaise severe 3-6 day and continuing.
Client presented  to receive Pfizer Booster lot#FJ6369. At approximately 1420 while in observation area client flagged EMT that she was feeling dizzy and felt ?phlegm? in her throat. Client sat in zero gravity chair.  RN was informed of client?s symptoms. Client was AAOX3 and was answering questions. Client states she had food and water before coming and denies having a reaction to the first series of Pfizer. Client has an allergy to dye contrast. Vitals at 1424 taken by BP 113/71 HR 98. RN informed client that she would give her Oral Benadryl. Client stated she wanted to get the Benadryl IM. RN administered IM Benadryl 1 ml on right arm at 1435. While RN was vaccinating fluid leaked from arm. Full dosage given was unable to be determined. RN elevated situation to clinical lead for guidance. Per County protocol we were unable to revaccinate client with another dose of Benadryl IM or Oral to prevent overdosing. The next step was to call EMS to have client be assessed and determine the next plan of care. RN informed client about having to call EMS and said,? I don?t want EMS, I just want Benadryl, I?ll go to the ER if I have to?. RN called EMS for client to be assessed. While on the phone with EMS, client told RN she didn?t want EMS and was refusing care. 911 operator told RN they wouldn?t come if client was refusing. 911 call was deactivated. Client was agitated and stated she was just going to go home. Client insisted on taking Benadryl RN explained to client that we couldn?t do it due to prevent overdosing. RN offered EMS services once again and client refused. EMS was on their way to assess another client and was welcomed to stay and wait. Client refused and stated she was going to leave. RN told client?s husband to seek emergency care and follow up with Primary care provider for any other concerns. He verbalized understanding. At 1509 client left vaccination site in a steady gait before EMS arrived.